FDA-Cleared Ciprofloxacin 0.002-32 MTS™
Liofilc
hem has received clearance from the FDA to market in the United States the Ciprofloxacin 0.002-32 MTS™ (MIC Test Strip), a quantitative assay for determining the Minimum Inhibitory Concentration (MIC) of Ciprofloxacin.
Ciprofloxacin MTS™ has been shown to be active both clinically and in vitro against the following Gram-negative bacteria, according to the FDA drug approved label:
C. freundii, C. koseri, E. cloacae, E. coli, M. Morganii, K. pneumoniae, P. mirabilis, P. vulgaris, P. rettgeri, P. stuartii, P. aeruginosa, S. marcescens.